Literature DB >> 21234606

Vitamin E for preventing chemotherapy-induced peripheral neuropathy.

Andreas A Argyriou, Haralabos P Kalofonos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21234606     DOI： 10.1007/s00520-011-1090-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  7 in total

1.  A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.

Authors:  Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiridon Papapetropoulos; Panagiotis Polychronopoulos; Haralabos P Kalofonos
Journal:  Support Care Cancer       Date:  2006-04-19       Impact factor: 3.603

Review 2.  Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.

Authors:  Guido Cavaletti; Barbara Frigeni; Francesca Lanzani; Laura Mattavelli; Emanuela Susani; Paola Alberti; Diego Cortinovis; Paolo Bidoli
Journal:  Eur J Cancer       Date:  2010-01-04       Impact factor: 9.162

3.  Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.

Authors:  Andreas A Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiridon Papapetropoulos; Panagiotis Polychronopoulos; Haralabos P Kalofonos
Journal:  J Pain Symptom Manage       Date:  2006-09       Impact factor: 3.612

4.  The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.

Authors:  Lisa A Kottschade; Jeff A Sloan; Miroslaw A Mazurczak; David B Johnson; Bronagh P Murphy; Kendrith M Rowland; Deanne A Smith; Alan R Berg; Philip J Stella; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2010-10-09       Impact factor: 3.603

5.  Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.

Authors:  A Pace; D Giannarelli; E Galiè; A Savarese; S Carpano; M Della Giulia; A Pozzi; A Silvani; P Gaviani; V Scaioli; B Jandolo; L Bove; F Cognetti
Journal:  Neurology       Date:  2010-03-02       Impact factor: 9.910

Review 6.  Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.

Authors:  A A Argyriou; V Zolota; O Kyriakopoulou; H P Kalofonos
Journal:  J BUON       Date:  2010 Jul-Sep       Impact factor: 2.533

7.  The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Authors:  Guido Cavaletti; Barbara Frigeni; Francesca Lanzani; Marialuisa Piatti; Stefania Rota; Chiara Briani; Gabriella Zara; Rosaria Plasmati; Francesca Pastorelli; Augusto Caraceni; Andrea Pace; Mariagrazia Manicone; Andrea Lissoni; Nicoletta Colombo; Giulia Bianchi; Claudio Zanna
Journal:  J Peripher Nerv Syst       Date:  2007-09       Impact factor: 3.494
  7 in total
  3 in total

1.  Second response to the letter to the editor referencing the manuscript the "use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial".

Authors:  L Kottschade; J Sloan; C Loprinzi
Journal:  Support Care Cancer       Date:  2012-10-31       Impact factor: 3.603

2.  The search for treatments to reduce chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; Charles L Loprinzi; Axel Grothey; Lauren E Ta
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 3.  NCS-1 is a regulator of calcium signaling in health and disease.

Authors:  Göran R Boeckel; Barbara E Ehrlich
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-05-08       Impact factor: 4.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.